In order to effectively handle collection and analysis of huge volumes of vital data, a leader from IQVIA advises bringing on people up to the challenge.
A leader from the cancer patient matching and analysis solutions firm discusses how and other forces are pushing innovation in the oncology research space.
This year the conference brings its content, focused on the intersection of clinical research and patient care, from the real world to the virtual one.
The pharmaceutical firm’s More to uS is a UK-centered campaign that shares stories of people living (and thriving) after a multiple sclerosis diagnosis.
eClinical Solutions, a provider of clinical data service solutions, has seen an increase in interest in clinical data platform and other digital products.
A veteran with more than 20 years of experience talks about the vitality of recruiting an inclusive patient population, and the perils of falling short.
Companies like Biofourmis, THREAD and other virtual tech specialists have seen infusions of funds from investors bullish on decentralized clinical trials.
TeleConsent empowers trial teams to obtain informed consent and re-consent from patients participating in clinical studies, within a fully remote system.
The drug discovery and pharma companies have extended their agreement to collaborate on development of new treatments for a range of therapeutic areas.
A leader from the clinical trial technology firm shares how direct data capture and other solutions can address the unique needs of such complex studies.
Innovative research by Tabula Rasa Healthcare uses simulation technology to analyze potential adverse drug events of potential therapies for the virus.
The pharma firm and health association plan to collaborate in order to help drive global action toward prevention and control of cardiovascular disease.
The companies will work together on solutions designed to enable sponsors to improve imaging, respiratory and cardiac safety data on decentralized trials.
The company has released a report revealing how clinical trial professionals are handling start-up, before and after COVID-19 first impacted the industry.
Led by the Spaulding Rehabilitation Hospital, a study by a 60-person task force shows ways mobile health tech can help mitigate the pandemic’s effects.
A leader from the speed-focused CRO talks about the specialized needs of precision medicine trials, and how sites and sponsors can succeed on such studies.
A leader from home-based clinical services firm Illingworth Research Group talks about the evolution of mobile nursing and how it can keep trials going.
A leader from the clinical trial patient engagement specialist discusses how clinical trial teams can tackle tricky travel issues in the face of the pandemic.
